Welcome to Santa Cruz Biotechnology!

L-FABP Antibodies

Santa Cruz Biotechnology, Inc. offers a broad range of L-FABP antibodies. Select L-FABP antibodies from several monoclonal and/or polyclonal L-FABP antibodies listed below. View detailed L-FABP antibody specifications by linking to the specific product blocks. Select appropriate L-FABP antibodies for your research by isotype, epitope, applications and species reactivity. L-FABP gene silencer products in siRNA, shRNA Plasmid, shRNA Lentiviral Particle and CRISPR/Cas9 Knockout Plasmid formats are also available.

Introducing HOVERcruz™,

a unique system for rapid identification of L-FABP Antibodies. Hover over product names in the table to see representative data for each product.

Live chat is now available! (click here)

Our live chat system is available to answer your product and ordering questions.

L-FABP (C-4)sc-374537mouse IgG2a7-126 (h)WB, IP, IF, IHC(P), ELISAm, h
L-FABP (F-9)sc-271591mouse IgG14-37 (h)WB, IP, IF, IHC(P), ELISAh > m, r
L-FABP (H-120)sc-50380rabbit IgG7-126 (h)WB, IP, IF, IHC(P), ELISAm, r, h, c, p2
L-FABP (T-19)sc-16065goat IgGinternal (h)WB, IF, ELISAh, c, b > m, r
L-FABP (N-20)sc-16064goat IgGN-terminal (h)WB, IP, IF, IHC(P), ELISAh, c, p > m, r2

L-FABP CRISPR/Cas9 Knockout Plasmids include:

L-FABP CRISPR/Cas9 KO Plasmid (h)sc-401554gene knockouthumanNEW
L-FABP CRISPR/Cas9 KO Plasmid (m)sc-420277gene knockoutmouseNEW

L-FABP siRNA, shRNA Plasmid and shRNA Lentiviral Particles gene silencers include:

siRNAsshRNA PlasmidsshRNA Lentiviral ParticlesCITATIONSRANKING
L-FABP siRNA (h): sc-41243L-FABP shRNA Plasmid (h):
L-FABP shRNA (h)
Lentiviral Particles: sc-41243-V
L-FABP siRNA (m): sc-41244L-FABP shRNA Plasmid (m):
L-FABP shRNA (m)
Lentiviral Particles: sc-41244-V

Fatty acid-binding proteins, designated FABPs, are a family of homologous cytoplasmic proteins that are expressed in a highly tissue-specific manner and play an integral role in the balance between lipid and carbohydrate metabolism. FABPs mediate fatty acid (FA) and/or hydrophobic ligand uptake, transport and targeting within their respective tissues. The mechanisms underlying these actions can give rise to both passive diffusional uptake and protein-mediated transmembrane transport of FAs. FABPs are expressed in adipocytes (A-FABP), brain (B-FABP), epidermis (E-FABP, also designated psoriasis-associated FABP or PA-FABP), muscle and heart (H-FABP, also designated mammary-derived growth inhibitor or MDGI), intestine (I-FABP), liver (L-FABP), myelin (M-FABP) and testis (T-FABP). Liver-specific FABP (L-FABP) expression is modulated by developmental, hormonal, dietary and pharmacological factors and is required for cholesterol synthesis and metabolism.